# Lakewood-Amedex Biotherapeutics (LABT): Completion of Series C Convertible Preferred, a 182% Day

> Source: IndicatorStack, https://indicatorstack.com/catalysts/labt-2026-11-05-release. Updated Nov 19, 2026, 4:35 AM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

Lakewood-Amedex Biotherapeutics (LABT) announced the completion of Series C convertible Preferred stock Redemption at 8:02 AM ET on Thursday, November 5, and the stock went from Wednesday’s $0.1914 close to as high as $0.9600. It finished the session +182.4% at $0.5406 on 187.3 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.

Catalyst Reaction by IndicatorStack, published Nov 19, 2026, 3:57 AM ET. NASDAQ: LABT, Biotechnology. All times ET.

## The numbers

- +182.4% Thursday’s close ($0.1914 to $0.5406, high $0.9600)
- 187.3× its 20-day average volume (754M shares on the day)
- 8:02 AM the catalyst crossed, ET (Thursday, before the open)
- 283K float, shares (2660.8× the float traded on Thursday)

## How the stack read it, checkpoint by checkpoint

| Checkpoint | When | Price | 5m stack bias | Compass |
| --- | --- | --- | --- | --- |
| Before | Wed close | $0.1926 | Bullish, firm | 15m and 1h split |
| Into the open | Thu 9:30 AM | $0.3851 | Bullish, strong | 15m and 1h up |
| 30 minutes in | Thu 10:00 AM | $0.4535 | Bullish, weakening | 15m and 1h up |
| At the close | Thu 4:00 PM | $0.5406 | Neutral | 15m and 1h up |
| Friday’s close | Fri 4:00 PM | $0.3727 | Neutral | 15m and 1h split |
| Monday’s close | Mon 4:00 PM | $0.4002 | Neutral | 15m and 1h up |
| Tuesday’s close | Tue 4:00 PM | $0.4107 | Bullish, firm | 15m and 1h up |

## Timeline

### Thursday, November 5

- 8:02 AM: Completion of Series C convertible Preferred stock Redemption (Press release, PRNewsWire)
- 8:45 AM: Premarket high $0.4419 (+130.9% from the prior close)
- 9:30 AM: Session low $0.3701
- 9:30 AM: Opened at $0.3834 (+100.3% from Wednesday’s $0.1914 close)
- 10:20 AM: Tripwire flagged a trap at the highs (a push through resistance that failed to hold, at $0.8387)
- 10:25 AM: Session high $0.9600
- 12:25 PM: 5-minute stack bias went neutral (at $0.6350, its inputs no longer agreeing)
- 12:35 PM: Tripwire flagged a trap at the lows (a push through support that failed to hold, at $0.6226)
- 12:50 PM: 5-minute stack bias turned bearish (at $0.5844)
- 2:55 PM: 5-minute stack bias went neutral (at $0.7000, its inputs no longer agreeing)
- 4:00 PM: Closed at $0.5406, +182.4% on the day (754M shares, 187.3× its 20-day average)

### Friday, November 6

- 6:15 AM: Trigger marked a long at $0.4096 (Hypothetical, default settings: reached $0.5243 at 7:00 AM for +4.7R (target))
- 7:00 AM: 5-minute stack bias turned bullish (at $0.5243)
- 8:45 AM: 5-minute stack bias turned bearish (at $0.4396)
- 9:30 AM: Opened at $0.4441 (−17.9% from Thursday’s $0.5406 close)
- 2:10 PM: Session low $0.3336
- 3:25 PM: 5-minute stack bias went neutral (at $0.3618, its inputs no longer agreeing)
- 4:00 PM: Closed at $0.3863, −28.5% on the day (36.1M shares, 0.9× its 20-day average)

### Monday, November 9

- 7:00 AM: Trigger marked a long at $0.4411 (Hypothetical, default settings: closed at $0.4140 at 7:30 AM for −1.2R (stop))
- 8:25 AM: 5-minute stack bias turned bearish (at $0.4001)
- 9:30 AM: Opened at $0.4350 (+12.6% from Friday’s $0.3863 close)
- 9:45 AM: 5-minute stack bias went neutral (at $0.4350, its inputs no longer agreeing)
- 10:15 AM: 5-minute stack bias turned bearish (at $0.3962)
- 1:15 PM: Session low $0.3714
- 3:25 PM: 5-minute stack bias went neutral (at $0.3900, its inputs no longer agreeing)
- 4:00 PM: Closed at $0.4180, +8.2% on the day (13.5M shares, 0.3× its 20-day average)

### Tuesday, November 10

- 8:25 AM: 5-minute stack bias turned bullish (at $0.3822)
- 9:00 AM: 5-minute stack bias turned bearish (at $0.3602)
- 9:30 AM: Session low $0.3501
- 9:30 AM: Opened at $0.3640 (−12.9% from Monday’s $0.4180 close)
- 9:40 AM: 5-minute stack bias turned bullish (at $0.4290)
- 11:45 AM: 5-minute stack bias went neutral (at $0.3943, its inputs no longer agreeing)
- 12:00 PM: 5-minute stack bias turned bearish (at $0.3851)
- 1:00 PM: 5-minute stack bias went neutral (at $0.4146, its inputs no longer agreeing)
- 1:10 PM: 5-minute stack bias turned bullish (at $0.4098)
- 4:00 PM: Closed at $0.4160, −0.5% on the day (4.4M shares, 0.1× its 20-day average)
- 5:20 PM: Current report (Form 8-K) filed (Accepted by the SEC at 5:20:52 PM ET)

## Before the catalyst (Wednesday, November 4)

Lakewood-Amedex Biotherapeutics closed Wednesday at $0.1914. The 5-minute stack bias was bullish (firm), since 2:20 PM: over VWAP 0.1827 and a rising SMA, momentum up and trend strength with the buyers. Compass read “15m and 1h split” (15m ↑ 1h ↘ 2h ↘ 4h ↘ D ↓). Undertow: buying drying up, price higher, flow lower. Tripwire: Longs: Clean, nothing major in the way. Its Next row read “Buying drying up near 0.1924, giveback risk rising”.

Over the year before, it had traded between $0.1687 and $98.20.

## The release and a 182% session (Thursday, November 5)

The release crossed at 8:02 AM ET. It opened at $0.3834, +100.3%, and the regular session ranged from $0.3701 to $0.9600 before closing at $0.5406. It did this on a day SPY fell 4.4% and XBI, the biotechnology ETF, fell 6.7%.

Into the open the stack read it as bullish (strong) with 2 of 2 higher timeframes up, and Undertow read “buyers in control”. Thirty minutes in, the picture had changed: price was below VWAP at $0.4805 and the Next row read “Pullback, support to hold at 0.4265 (slow EMA)”. By the close the 5-minute bias was neutral, while Compass still read “15m and 1h up”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.

## The session after (Friday, November 6)

It opened at $0.4441 (−17.9%) and traded from $0.3336 to $0.4874, closing at $0.3863, −28.5% on 36.1M shares, still 0.9 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h split” (15m ↓ 1h ↑ 2h ↗ 4h ↘ D ↓). Undertow: buyers lead, no large size yet. Tripwire: Shorts: Clean, nothing major in the way.

## The session after (Monday, November 9)

It opened at $0.4350 (+12.6%) and traded from $0.3714 to $0.4500, closing at $0.4180, +8.2% on 13.5M shares, still 0.3 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h up” (15m ↑ 1h ↑ 2h ↗ 4h ↘ D ↘). Undertow: hidden selling, price higher, flow lower. Tripwire: Shorts: Caution, buying tape pushing against it.

## The session after (Tuesday, November 10)

It opened at $0.3640 (−12.9%) and traded from $0.3501 to $0.4350, closing at $0.4160, −0.5% on 4.4M shares, still 0.1 times its 20-day average. The 5-minute stack bias was bullish (firm), since 1:10 PM: over VWAP 0.4040 and a rising SMA, momentum up and trend strength with the buyers. Compass read “15m and 1h up” (15m ↗ 1h ↑ 2h ↑ 4h ↘ D ↓). Undertow: sellers pushing back, flow turning against the bias. Tripwire: Longs: Clean, nothing major in the way.

After hours it last traded at $0.4142, with Undertow reading “buyers in control”.

## Supply

|  |  |  |
| --- | --- | --- |
| Shares outstanding | 1.8M | as reported to the SEC |
| Float | 283K | 16% of shares outstanding |
| Reverse splits on record | 1 | 1-for-10 reverse split, June 22, 2026 |

## Sources

- Tue Nov 10, 5:20 PM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/2079272/000121390026118127/ea0311576-8k_lakewood.htm
- Thu Nov 5, 8:02 AM ET, Press release: Completion of Series C convertible Preferred stock Redemption (PRNewsWire) https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-completion-of-series-c-convertible-preferred-stock-redemption-302930368.html

## Questions

### Why did LABT stock go up on November 5?

Lakewood-Amedex Biotherapeutics (LABT) announced the completion of Series C convertible Preferred stock Redemption at 8:02 AM ET on Thursday, November 5, and the stock went from Wednesday’s $0.1914 close to as high as $0.9600. It finished the session +182.4% at $0.5406 on 187.3 times its 20-day average volume. The reaction describes the sequence and infers no cause.

### What did Lakewood-Amedex Biotherapeutics announce on November 5, 2026?

Lakewood-Amedex Biotherapeutics (LABT) announced the completion of Series C convertible Preferred stock Redemption at 8:02 AM ET on Thursday, November 5.

### How did LABT stock trade on November 5?

LABT opened at $0.3834, +100.3% from the prior close of $0.1914, traded between $0.3701 and $0.9600 in the regular session and closed at $0.5406, +182.4%, on 754M shares.

### How did LiveChart’s stack read LABT at the close on November 5?

At the 4:00 PM ET close the 5-minute stack bias on LABT was neutral, Compass read “15m and 1h up” and Undertow read “hidden buying”. Each turn of the read is on this page’s timeline.

### What does LiveChart’s stack read on LABT now?

The read on this page is fixed at each moment it describes. LiveChart reads LABT on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.

Chart: https://indicatorstack.com/chart/LABT. LABT catalyst history: https://indicatorstack.com/catalysts/stock/LABT

Each reaction describes what happened and when, infers no cause and takes no view on what comes next. Past reactions don’t predict future ones.

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
